Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 37
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Title
Phase
Protocol IDs
Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children
Phase III, Phase II
EUDRACT 2005-002618-40
BfArM-4030755, EC-105/05, DKS 2006.01, NCT00749723
Radiation Therapy and Combination Chemotherapy Followed by Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor
Phase III
SJCRH-SJMB03
NCT00085202
Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma
Phase III
COG-ACNS0334
ACNS0334, NCT00336024
Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors
Phase III
CHLA-HEAD-START-III
CHLA-HSIII, CHLA-2004-020, CHLA-04.020, NCT00392886, UMN-MT2004-06
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
Phase III
COG-ACNS0332
ACNS0332, NCT00392327
A Phase I/II Study of the Photon Radiosurgery System
Phase II, Phase I
CNS 0201
NCT00179907
Intracerebral Clysis in Treating Patients With Recurrent Primary Brain Tumors
Phase II, Phase I
R01 CA 89395-01
Topotecan, Brain Tumors, Intracerebral Clysis, NCT00452959
A Multi-Center Phase I Study of AP23573 in Pediatric Patients With Advanced Solid Tumors
Phase II, Phase I
SUN08-01
NCT00704054
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
Phase II, Phase I
CHNMC-07053
07053, CA180 121, NCT00788125
Antineoplaston Therapy in Treating Children With Brain Tumors
Phase II
BC-BT-10
NCT00003458
1
2
3
4
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute